alyssa - OT - got this article on insomnia from vitacost today-Eileen

[Guest guest]

To ensure delivery to your inbox, please add newsletter@... to your

address book.

Are you having trouble viewing this email? See it here.

Sunday, June 28, 2009

NSI GABA -- 200 Capsules

50% off

Retail price:

$29.99

Our price:

$14.99

Rating:

NSI GABA -- 300 Capsules

51% off

Retail price:

$44.99

Our price:

$21.99

Rating:

Over 22,000 Health Products

At Your Fingertips!

In Some Insomnia Patients, Brain Just Won't Shut Down

Abnormal levels of a neurochemical are linked to sleep disorder, study finds

(HealthDay News) -- Adults with primary insomnia have a neurochemical

abnormality that makes it difficult to " shut down " the mind at night for sleep,

new research has found.

Researchers measured the levels of gamma-aminobutyric acid (GABA) in 16 adult

men and women with primary insomnia and 16 men and women deemed normal sleepers.

Primary insomnia is difficulty falling sleep or staying asleep at night for over

a period of at least one month, according to the American Academy of Sleep

Medicine. Unlike most cases of insomnia, primary insomnia can't be attributed to

a psychiatric, medical or environmental cause.

The new study found that people who had suffered from primary insomnia for more

than six months had 30 percent lower levels of GABA.

GABA, the most common inhibitory transmitter in the brain, slows overall

activity in many brain areas.

The research was to be presented June 9 at the annual meeting of the Associated

Professional Sleep Societies, in Seattle.

The findings suggest that primary insomnia is the result of a neurobiological

state of hyperarousal, and that this state remains throughout the day and night,

affecting the individual's mind and body, according to a news release from the

American Academy of Sleep Medicine. About one-quarter of people with insomnia

have this type, the Academy stated.

Understanding that primary insomnia is associated with a specific neurochemical

deficiency helps validate the often-misunderstood complaint of insomnia,

explained lead study author Dr. Winkelman of Brigham and Women's Hospital

at Harvard Medical School in Boston.

" Recognition that insomnia has manifestations in the brain may increase the

legitimacy of those who have insomnia and report substantial daytime

consequences, " Winkelman said. " Insomnia is not just a phenomenon observed at

night, but has daytime consequences for energy, concentration and mood. "

More information

The U.S. National Institutes of Health has more on primary insomnia.

--

SOURCE: American Academy of Sleep Medicine, news release, June 9, 2009